Literature DB >> 12486285

Late clinical and magnetic resonance imaging follow up of Nipah virus infection.

C C T Lim1, W L Lee, Y S Leo, K E Lee, K P Chan, A E Ling, H Oh, A P Auchus, N I Paton, F Hui, P A Tambyah.   

Abstract

The Nipah virus is a newly identified paramyxovirus responsible for an outbreak of fatal encephalitis in Malaysia and Singapore. This paper reports the follow up clinical and magnetic resonance imaging findings in 22 affected subjects. Of 13 patients with encephalitis, one died, one was lost to follow up, and seven recovered. Among the four remaining patients, one had residual sixth nerve palsy, another suffered from severe clinical depression, and a third patient had evidence of retinal artery occlusion. One patient with delayed onset Horner syndrome had a single lesion in the cervical spinal cord. The brain magnetic resonance findings were stable or improved in nine patients over 18 months of follow up. Among a second group of nine asymptomatic seropositive abattoir workers, magnetic resonance examination in seven subjects revealed discrete small lesions in the brain; similar to those detected in encephalitis patients. These findings suggest that in addition to encephalitis, the newly discovered Nipah virus affects the spinal cord and the retina. Late clinical and radiological findings can occur in Nipah virus infections as with other paramyxoviruses.

Entities:  

Mesh:

Year:  2003        PMID: 12486285      PMCID: PMC1738187          DOI: 10.1136/jnnp.74.1.131

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Nipah virus: vaccination and passive protection studies in a hamster model.

Authors:  V Guillaume; H Contamin; P Loth; M-C Georges-Courbot; A Lefeuvre; P Marianneau; K B Chua; S K Lam; R Buckland; V Deubel; T F Wild
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 2.  Armies of pestilence: CNS infections as potential weapons of mass destruction.

Authors:  B L Hart; L Ketai
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

3.  Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model.

Authors:  Sarah C Genzer; Stephen R Welch; Florine E M Scholte; Jessica R Harmon; JoAnn D Coleman-McCray; Michael K Lo; Joel M Montgomery; Stuart T Nichol; Christina F Spiropoulou; Jessica R Spengler
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

Review 4.  Neuroimaging of infections.

Authors:  Oliver Kastrup; Isabel Wanke; Matthias Maschke
Journal:  NeuroRx       Date:  2005-04

Review 5.  Henipavirus receptor usage and tropism.

Authors:  Olivier Pernet; Yao E Wang; Benhur Lee
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Susac syndrome in a young child.

Authors:  Thomas Jose Eluvathingal Muttikkal; Surjith Vattoth; Venugopal Naik Keluth Chavan
Journal:  Pediatr Radiol       Date:  2007-05-03

7.  Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.

Authors:  Oscar A Negrete; David Chu; Hector C Aguilar; Benhur Lee
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

Review 8.  Nipah Virus Infection.

Authors:  Brenda S P Ang; Tchoyoson C C Lim; Linfa Wang
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

Review 9.  Neuroimaging in Zoonotic Outbreaks Affecting the Central Nervous System: Are We Fighting the Last War?

Authors:  G X Goh; K Tan; B S P Ang; L-F Wang; C C Tchoyoson Lim
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

10.  In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model.

Authors:  Stephen R Welch; Florine E M Scholte; Jessica R Harmon; JoAnn D Coleman-McCray; Michael K Lo; Joel M Montgomery; Stuart T Nichol; Christina F Spiropoulou; Jessica R Spengler
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.